English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [876]
News [2014]
Articles [108]
Editorials [8]
Conferences [68]
elearning [7]
ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic castration-resistant prostate cancer
ASCO GU 2022: Olaparib plus abiraterone reduced risk of disease progression by 34% vs. standard-of-c...
ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
ASCO GU: MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate c...
ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer
ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer
ASCO GU 2022: New genetic risk score stratifies lifetime risk of dying of prostate cancer in diverse populations
ASCO GU 2022: New genetic risk score stratifies lifetime risk of dying of prostate cancer in diverse...
New dietary tool in cancer battle
New dietary tool in cancer battle
Colorectal cancers raise defensive barrier in response to chemotherapy
Colorectal cancers raise defensive barrier in response to chemotherapy
Approval for testicular re-implantation to restore fertility after childhood cancer treatment
Approval for testicular re-implantation to restore fertility after childhood cancer treatment
NICE recommends nivolumab plus ipilimumab for untreated advanced kidney cancer in intermediate or poor-risk patients
NICE recommends nivolumab plus ipilimumab for untreated advanced kidney cancer in intermediate or po...
Genetic clues link lipoprotein A to prostate cancer risk
Genetic clues link lipoprotein A to prostate cancer risk
Faulty BRCA genes linked to prostate and pancreatic cancers
Faulty BRCA genes linked to prostate and pancreatic cancers
<1234567...202>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307